Vivo Capital IX LLC 13D/13G Filings for Sierra Oncology, Inc. (SRRA)

Vivo Capital IX LLC 13D and 13G filings for Sierra Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-07-05
5:06 pm
Sale		2022-07-0113GSierra Oncology, Inc.
SRRA		Vivo Capital IX LLC0
0.000%		-2,735,852decrease
(Position Closed)		Filing
2022-02-11
5:22 pm
Purchase		2022-01-3113GSierra Oncology, Inc.
SRRA		Vivo Capital IX LLC2,735,852
14.700%		799,999increase
(+41.33%)		Filing
2021-11-05
5:00 pm
Purchase		2021-11-0513GSierra Oncology, Inc.
SRRA		Vivo Capital IX LLC1,935,853
14.800%		480,277increase
(+33.00%)		Filing